Digg It
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > List Building > List Building - How to Test a Squeeze Page I

Tags

  • pages
  • involved
  • product
  • squeeze pages
  • companies involved

  • Links

  • Writing a Screenplay: Constant Gardener (2005) Deconstructed
  • Online Memorial - A Dedication of Love for Your Departed Loved Ones
  • College Savings
  • Digg It - List Building - How to Test a Squeeze Page I

    It is critically important that you test the web copy on your squeeze page.
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    I have squeeze pages that convert at 10%, and I have squeeze pages that c
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    nvert at 65%. This varies dramatically based on the traffic source and the
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    squeeze page itself. Sometimes a small change in the script will create a
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ig change in the conversion rate.

    Think about this. Assume that your aver
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ge visitor cost is 10 cents. Assume that your average conversion rate is 10
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    . That means your cost per subscriber is $1. Imagine that you can increas
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    the conversion rate on that particular source of traffic to 30%. Your cos
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    per subscriber will go down to 33 cents.

    You can look at that two ways.
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ou can either afford more subscribers on the same budget, or you can increa
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    e the profit per subscriber – or both.

    One thing that is important to reme
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    mber is that each traffic source will convert differently, and will convert
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    differently on different squeeze pages.

    For example, a referred visitor or
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    an article generated visitor may not need much ad copy to get them to subsc
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ibe – when they get to your squeeze page they are already prepared to opt i
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    , regardless of the offer – and in fact may convert at a lower rate if they
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    have to read a long article to get to the opt in box.

    However, non-referre
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    (or cold) traffic may need to read 300-500 words from you before they will
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    trust you enough to give you their name and email address.

    So in these two
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    cases, the source of traffic dictates the type and copy of the squeeze page


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/71367/diggit-List-Building--How-to-Test-a-Squeeze-Page-I.html">List Building - How to Test a Squeeze Page I</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/71367/diggit-List-Building--How-to-Test-a-Squeeze-Page-I.html]List Building - How to Test a Squeeze Page I[/url]

    Related Articles:

    Recruiting Professionals for Your Network Marketing Business

    Creating Awareness For Charities

    Are You Marketing Brilliantly?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com